Cargando…

Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study

Cancer chemotherapy-induced cognitive impairment (chemobrain) is a major complication that affects the prognosis of therapy. Our study evaluates the nootropic-like activity of levetiracetam (LEVE) against doxorubicin (DOX)-induced memory defects using in vivo and molecular modelling. Rats were treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mani, Vasudevan, Arfeen, Minhajul, Rabbani, Syed Imam, Shariq, Ali, Amirthalingam, Palanisamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653834/
https://www.ncbi.nlm.nih.gov/pubmed/36364190
http://dx.doi.org/10.3390/molecules27217364
_version_ 1784828779052400640
author Mani, Vasudevan
Arfeen, Minhajul
Rabbani, Syed Imam
Shariq, Ali
Amirthalingam, Palanisamy
author_facet Mani, Vasudevan
Arfeen, Minhajul
Rabbani, Syed Imam
Shariq, Ali
Amirthalingam, Palanisamy
author_sort Mani, Vasudevan
collection PubMed
description Cancer chemotherapy-induced cognitive impairment (chemobrain) is a major complication that affects the prognosis of therapy. Our study evaluates the nootropic-like activity of levetiracetam (LEVE) against doxorubicin (DOX)-induced memory defects using in vivo and molecular modelling. Rats were treated with LEVE (100 and 200 mg/kg, 30 days) and chemobrain was induced by four doses of DOX (2 mg/kg, i.p.). Spatial memory parameters were evaluated using an elevated plus maze (EPM) and Y-maze. Additionally, acetylcholinesterase (AChE) and the neuroinflammatory biomarkers cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), nuclear factor-κB (NF-κB), and tumor necrosis factor-alpha (TNF-α) were analyzed using brain homogenate. PharmMapper was used for inverse docking and AutoDock Vina was used for molecular docking. LEVE treatment significantly diminished the DOX-induced memory impairment parameters in both the EPM and Y-maze. In addition, the drug treatment significantly reduced AChE, COX-2, PGE2, NF-κB, and TNF-α levels compared to DOX-treated animals. The inverse docking procedures resulted in the identification of AChE as the potential target. Further molecular modelling studies displayed interactions with residues Gly118, Gly119, and Ser200, critical for the hydrolysis of ACh. Analysis of the results suggested that administration of LEVE improved memory-related parameters in DOX-induced animals. The ‘nootropic-like’ activity could be related to diminished AChE and neuroinflammatory mediator levels.
format Online
Article
Text
id pubmed-9653834
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96538342022-11-15 Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study Mani, Vasudevan Arfeen, Minhajul Rabbani, Syed Imam Shariq, Ali Amirthalingam, Palanisamy Molecules Article Cancer chemotherapy-induced cognitive impairment (chemobrain) is a major complication that affects the prognosis of therapy. Our study evaluates the nootropic-like activity of levetiracetam (LEVE) against doxorubicin (DOX)-induced memory defects using in vivo and molecular modelling. Rats were treated with LEVE (100 and 200 mg/kg, 30 days) and chemobrain was induced by four doses of DOX (2 mg/kg, i.p.). Spatial memory parameters were evaluated using an elevated plus maze (EPM) and Y-maze. Additionally, acetylcholinesterase (AChE) and the neuroinflammatory biomarkers cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), nuclear factor-κB (NF-κB), and tumor necrosis factor-alpha (TNF-α) were analyzed using brain homogenate. PharmMapper was used for inverse docking and AutoDock Vina was used for molecular docking. LEVE treatment significantly diminished the DOX-induced memory impairment parameters in both the EPM and Y-maze. In addition, the drug treatment significantly reduced AChE, COX-2, PGE2, NF-κB, and TNF-α levels compared to DOX-treated animals. The inverse docking procedures resulted in the identification of AChE as the potential target. Further molecular modelling studies displayed interactions with residues Gly118, Gly119, and Ser200, critical for the hydrolysis of ACh. Analysis of the results suggested that administration of LEVE improved memory-related parameters in DOX-induced animals. The ‘nootropic-like’ activity could be related to diminished AChE and neuroinflammatory mediator levels. MDPI 2022-10-29 /pmc/articles/PMC9653834/ /pubmed/36364190 http://dx.doi.org/10.3390/molecules27217364 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mani, Vasudevan
Arfeen, Minhajul
Rabbani, Syed Imam
Shariq, Ali
Amirthalingam, Palanisamy
Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study
title Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study
title_full Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study
title_fullStr Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study
title_full_unstemmed Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study
title_short Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study
title_sort levetiracetam ameliorates doxorubicin-induced chemobrain by enhancing cholinergic transmission and reducing neuroinflammation using an experimental rat model and molecular docking study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653834/
https://www.ncbi.nlm.nih.gov/pubmed/36364190
http://dx.doi.org/10.3390/molecules27217364
work_keys_str_mv AT manivasudevan levetiracetamamelioratesdoxorubicininducedchemobrainbyenhancingcholinergictransmissionandreducingneuroinflammationusinganexperimentalratmodelandmoleculardockingstudy
AT arfeenminhajul levetiracetamamelioratesdoxorubicininducedchemobrainbyenhancingcholinergictransmissionandreducingneuroinflammationusinganexperimentalratmodelandmoleculardockingstudy
AT rabbanisyedimam levetiracetamamelioratesdoxorubicininducedchemobrainbyenhancingcholinergictransmissionandreducingneuroinflammationusinganexperimentalratmodelandmoleculardockingstudy
AT shariqali levetiracetamamelioratesdoxorubicininducedchemobrainbyenhancingcholinergictransmissionandreducingneuroinflammationusinganexperimentalratmodelandmoleculardockingstudy
AT amirthalingampalanisamy levetiracetamamelioratesdoxorubicininducedchemobrainbyenhancingcholinergictransmissionandreducingneuroinflammationusinganexperimentalratmodelandmoleculardockingstudy